About Mabtech
Mabtech is a company based in Nacka (Sweden) founded in 1986 was acquired by EQT in January 2024. Mabtech offers products and services including ELISpot Kits, FluoroSpot Kits, ELISA Kits, Mabtech IRIS™ 2, and EYRAplex Kits. Mabtech operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Shanghai OPM Biosciences, among others.
- Headquarter Nacka, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mabtech
Mabtech offers a comprehensive portfolio of products and services, including ELISpot Kits, FluoroSpot Kits, ELISA Kits, Mabtech IRIS™ 2, and EYRAplex Kits.
Kits for detecting immune cell secretions in research applications.
Advanced kits for fluorescent detection of cellular responses.
Standard kits for enzyme-linked immunosorbent assays in diagnostics.
Instrument for analyzing ELISpot and FluoroSpot assay data.
Bead-based kits for fluidics-free multiplex immunoassays.
People of Mabtech
Unlock access to complete
Funding Insights of Mabtech
Investors in Mabtech
Mabtech has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include EQT, European Union and IK Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pivate equity firm that focuses on investing in healthcare and nutrition companies
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward small and medium-sized businesses.
|
Locked | Locked | Locked | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked |
Investor details for Mabtech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mabtech
Investment portfolio details for Mabtech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mabtech
Detailed financials for Mabtech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mabtech Comparisons
Peer comparison for Mabtech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mabtech
Mabtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Shanghai OPM Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Mabtech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mabtech
Complete news archive for Mabtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mabtech
Mabtech was founded in 1986 and raised its 1st funding round 30 years after it was founded.
Mabtech is headquartered in Nacka, Sweden. It is registered at Nacka, Stockholm County, Sweden.
Mabtech was founded in 1986 in Nacka, Sweden, where operations in the biotechnology sector are conducted. Antibodies, ELISA kits, ELISpot kits, and FluoroSpot kits are developed, along with related reagents. These products support various research applications. Collaborations with research institutes are maintained to execute RD programs focused on antibody technologies.
Mabtech's top competitors include Sino Biological, GenScript and Y-Biologics.
Mabtech offers ELISpot Kits, FluoroSpot Kits, ELISA Kits, Mabtech IRIS™ 2, and EYRAplex Kits.
Mabtech has 4 investors. Key investors include EQT, European Union, IK Partners, and Merieux Equity Partners.